O slideshow foi denunciado.

ALLERGIC RHINITIS

0

Compartilhar

Carregando em…3
×
1 de 9
1 de 9

ALLERGIC RHINITIS

0

Compartilhar

Baixar para ler offline

Allergic rhinitis, also known as hay fever, is a type
of inflammation in the nose which occurs when
the immune system overreacts to allergens in the
air. Signs and symptoms include a runny or stuffy
nose, sneezing, red, itchy, and watery eyes, and
swelling around the eyes.

Allergic rhinitis, also known as hay fever, is a type
of inflammation in the nose which occurs when
the immune system overreacts to allergens in the
air. Signs and symptoms include a runny or stuffy
nose, sneezing, red, itchy, and watery eyes, and
swelling around the eyes.

Mais Conteúdo rRelacionado

ALLERGIC RHINITIS

  1. 1. Allergic Rhinitis MARKET INSIGHT, EPIDEMIOLOGY AND MARKET FORECAST 2027 1
  2. 2. Allergic Rhinitis Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air. Signs and symptoms include a runny or stuffy nose, sneezing, red, itchy, and watery eyes, and swelling around the eyes. 2
  3. 3. Allergic rhinitis 3 Genetic and environmental factors Stuffy nose, sneezing, red, itchy and watery eyes, swelling around the eyes ~20% ( Western countries ) Allergy and immunology
  4. 4. Classification 4 01 02 03 Allergic rhinitis may be seasonal or perennial. Perennial allergic rhinitis occurs throughout the year. This type of allergic rhinitis is commonly seen in younger children. 04 It may also be classified as Mild-Intermittent, Moderate-Severe intermittent, Mild-Persistent, and Moderate-Severe Persistent. Seasonal allergic rhinitis occurs in particular during pollen seasons. It does not usually develop until after 6 years of age.
  5. 5. Market Insights 5 Market size of allergic rhinitis in the US was found to be xxx in 2016. The market size of allergic rhinitis shall increase at a CAGR of XX% during forecast period (2018-2027) Pharmacotherapy and immunotherapy are recommended for treating Allergic RhinitisLaunch of therapies such as Omalizumab (Novartis Pharmaceuticals) and GSP 301 (Glenmark Pharma) shall fuel the growth of the market. Targeted immunotherapy is effective in changing the natural course of Allergic Rhinitis.
  6. 6. Emerging Therapy Analysis 6 Omalizumab GSP 301 Launch of emerging therapies such as Omalizumab (Novartis Pharmaceuticals) GSP 301 (Glenmark Pharmaceuticals Ltd) And other effective therapies, are expected to change the treatment landscape of Allergic Rhinitis in upcoming years.
  7. 7. COMPLETE INFORMATION 7 For complete information please click the link below Or write us at info@delveinsight.com CLICK HERE
  8. 8. ABOUT DELVEINSIGHT Insight across value chain to help organization make important business decision through the use and analysis of actionable market intelligence. 8 ABOUT DELVEINSIGHT MISSION VISION • Delveinsight , market research & consulting firm provides end to end comprehensive solutions to the life science industry. • We help our customers in best decision-making through our expertise in research & analysis & comes out with unmatched data & forecasts. • To be the most trusted market research & business consulting firm worldwide. • To be the renowned & premier data driven solutions providers among pharma & biotech companies.
  9. 9. 9 Contact us : info@delveinsight.com +91-11-45689769 www.delveinsight.com blog/delveinsight/ twitter/delveinsight/ Linkedin/delveinsight c

×